ENSC · Ensysce Biosciences, Inc. · Exempt Offerings
$0.46
+0.01 (+1.24%)
At close · Sep 18
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, among others, raise substantial doubt about the Company's ability to continue as a going concern. While the Company believes in the viability of its strategy to ultimately realize revenues and in its ability to raise additional funds, management cannot be certain that additional funding will be available on acceptable terms, or at all. The Company's ability to continue as a going concern is dependent upon its ability to obtain adequate financing and achieve profitable operations. As a result, these plans do not alleviate substantial doubt about the Company's ability to continue as a going concern for a period of 12 months following the date these consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$8.96M
Shares
19.46M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-08-20 | New | Other Health Care | $77,200,000 | $77,200,000 | 06b |
| 2025-04-25 | New | Other Health Care | $2,200,012 | $2,200,012 | 06b |
| 2025-04-14 | New | Other Health Care | $1,100,000 | $1,100,000 | 06b |
| 2024-09-12 | New | Other Health Care | $5,055,648 | $5,055,648 | 06b |
| 2024-02-21 | New | Other Health Care | $4,718,295 | $4,718,295 | 06b |
| 2023-03-01 | New | Other Health Care | $2,816,073 | $2,816,073 | 06b |
| 2022-07-08 | New | Other Health Care | $8,480,000 | $4,240,000 | 06b |
| 2021-10-06 | New | Other Health Care | $15,900,000 | $5,300,000 | 06b |
Showing 1–8 of 8 filings